The full-service CRO that shares your risk — from first-in-human to patient adherence.
A global, Swiss-based Contract Research Organization operating across 29 countries and three continents. Our own preclinical and Phase I facilities, the Trial-HUB® platform, and in-house patient-support teams — under a shared-risk, milestone-based partnership model.
- ROCHE
- MERCK
- ABBVIE
- ASTELLAS
- BMS
- One partner, the entire journey
From idea to market — and beyond
Most CROs stop at approval. We stay with the patient — our Patient Support Programs improve adherence, outcomes and brand performance long after the trial ends.
- Services
Full-service, digital & traditional
R&D · Preclinical
GLP non-clinical and toxicology studies in our own state-of-the-art research facility.
Clinical Research – Phase I
First-in-human in our own 70-bed clinical-pharmacology unit with 24/7 medical oversight.
Clinical Operations – II–IV
End-to-end global trial management across 29 countries and a 2,000+ site network.
Digital & Decentralized
Hybrid and decentralized (DCT) designs that widen recruitment and lift retention.
Data Science
CDISC-compliant data management & biostatistics — clean data, faster locks.
Compliance & Risk
Regulatory affairs & an independently structured QMS, audit-ready in every market.
Clinical Supply Chain
IP management, cold-chain and GDP-compliant global logistics — never the bottleneck.
Technology – Trial-HUB®
Proprietary IRT/EDC/CDISC platform on a single 21 CFR Part 11 database.
Patient Engagement
In-house clinicians running adherence programs — 55,000+ patients supported.
- Why CEBIS
Four reasons teams choose us
We share your risk
Shared-risk, milestone-based pricing ties our fees to your progress. For the right programs we co-invest as a private investor — controlling the risk as your CRO.
We own the facilities
A state-of-the-art preclinical GLP facility and a Phase I unit with 70 beds, on-site ICU, pharmacy, CLIA lab and 24/7 medical oversight.
One platform, no hand-offs
Trial-HUB® unifies IRT/IWRS, EDC, CDISC and medical coding on a single 21 CFR Part 11 / ISO 27001 & 9001 database.
Adherence by real clinicians
In-house doctors, psychologists, nurses and educators — not a call centre — supporting 55,000+ patients at >97% adherence.
- Global reach
29 countries. Three continents. One accountable partner.
Headquartered in Lugano, with our global operational hub in Bucharest and a US base in Houston — running studies across Europe, North America and Asia.
- Hubs — Lugano · Bucharest · Houston
- Study & program coverage
- Our signature differentiator
A CRO that puts its own capital where its confidence is
Only ~14% of drugs entering clinical trials win FDA approval — and a failed Phase III carries the cost of every trial before it. Our shared-risk model is built to change that equation for you.
- Shared-risk, milestone-based costing
- Private co-investment in clinical development for the right programs
- A Risk-Sharing Program targeting every trial-related cause of failure
- Technology
One platform, built in-house
Trial-HUB® unifies the whole data stack in a single secure system — with AI-assisted protocol and SAP design, so data stays clean from randomisation to submission.
- Trusted by leading life-science teams
What our clients say
A reliable partner delivering comprehensive services with expertise, efficiency and integrity.
Head of Clinical Operations
Roche
Provides excellent execution across a broad range of services — from patient support programs to the most sophisticated clinical trials.
Medical Manager
Merck
A real partnership. CEBIS takes the initiative in finding solutions whenever there is a difficulty.
Regional Ethics & Compliance
AbbVie
- ROCHE
- MERCK
- ABBVIE
- ASTELLAS
- BRISTOL-MYERS SQUIBB
Let’s scope your next study — or your next partnership
Tell us where you are in development. We’ll respond within one business day with how CEBIS can help, including whether a shared-risk model fits your program.